| Predicted Trait | |
| Reported Trait | Diabetic retinopathy |
| Mapped Trait(s) | diabetic retinopathy (EFO_0003770) |
| Score Construction | |
| PGS Name | PRS_DR |
| Development Method | |
| Name | LDpred |
| Parameters | P = 0.0024, rho = 0.001 |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 3,537,914 |
| Effect Weight Type | NR |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000203 |
| Citation (link to publication) | Forrest IS et al. Hum Mol Genet (2021) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 17,567 individuals (100%) |
| PGS Evaluation | |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
Europe PMC: 33704450 |
[ ,
62.21 % Male samples |
European (British) |
UKB |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM002190 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Retinal hemorrhage in inidividuals with type 2 diabetes | OR: 1.44 [1.03, 2.02] | — | — | — | — |
| PPM002185 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diabetic retinopathy in individuals with type 2 diabetes | OR: 1.12 [1.04, 1.2] | — | — | — | — |
| PPM002186 | PSS001066| European Ancestry| 978 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diabetic retinopathy in individuals with type 2 diabetes | OR: 1.22 [1.02, 1.41] | — | — | — | — |
| PPM002187 | PSS001065| African Ancestry| 1,925 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diabetic retinopathy in individuals with type 2 diabetes | OR: 1.15 [1.03, 1.28] | — | — | — | — |
| PPM002188 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diabetic retinopathy in individuals with type 2 diabetes | — | — | Odds Ratio (OR, top 10% vs bottom 10%): 1.8 [1.28, 2.55] | Age, sex, body mass index, PCs(1-20), history of hypertension, glucose levels | — |
| PPM002189 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diabetic retinopathy in individuals with type 2 diabetes | OR: 1.14 [1.05, 1.23] | — | — | PCs(1-20), type 2 diabetes duration, type 2 diabetes medication, hyperglycemia, elevated HbA1c, hypertension, hypercholesterolemia, hyperlipidemia, insomina, sleep apnea, age, sex, body mass index | — |
| PPM002191 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Diplopia in individuals with type 2 diabetes | OR: 1.31 [1.02, 1.7] | — | — | — | — |
| PPM002192 | PSS001067| Multi-ancestry (including European)| 6,079 individuals |
PGP000203 | Forrest IS et al. Hum Mol Genet (2021) |
Reported Trait: Time to diabetic retinopathy diagnosis in individuals with type 2 diabetes | HR: 1.13 [1.05, 1.21] | — | — | Age, sex, body mass index, PCs(1-20), history of hypertension, glucose levels | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS001065 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | African American or Afro-Caribbean | — | BioMe | — |
| PSS001066 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | European | — | BioMe | — |
| PSS001067 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | European | — | BioMe | — |
| PSS001067 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | African American or Afro-Caribbean | — | BioMe | — |
| PSS001067 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | Hispanic or Latin American | — | BioMe | — |
| PSS001067 | All individuals had type 2 diabetes (T2D). Cases were individuals with diabetic retinopathy (DR). T2D was ascertained with ICD-10 from E11.0-E11.9. DR was ascertained with an ICD-10 of E11.3. | — | [
|
— | Asian unspecified, Native American, NR | — | BioMe | — |